Döring et al., in a study of nuclear HER2 expression in hepatocytes in liver disease, identified HER2 positivity as a recent event in HCC development, but that unlikely is conserved in the progression to preneoplastic lesions [35]. This evidence concerns the gene ERBB2 and liver disorder.